Research Administration

• Code of Ethics
• Conduct of Clinical Research
• Consistent Treatment of Costs
• Cost Sharing Policy
• Cost Transfer Policy
• Effort Reporting Policy
• Ethical Interactions with Industry
• Existing Clinical Human Biospecimens Use and Transfer
• Export Control Compliance
• Foreign Influence in Research
• Fringe Benefit Costs
• Good Clinical Practice (GCP) Training Required for Conducting Clinical Trials
• Institutional Conflicts of Interest
• Institutional Office of Regulated Nonclinical Studies
• Maintaining Patient Confidentiality through the Appropriate Use and Disclosure of PHI
• Photography of Research Animals
• Principal Investigator Roles and Responsibilities
• Procurement Policy
• Registration of Clinical Trials in ClinicalTrials.gov
• Research Compliance Plan
• Research Conflicts of Interest
• Research Related Injury of a Subject Participating in a Clinical Investigation
• Use & Disclosure of PHI for Research

• Submission of Applications for Institutional Approvals

• Resolving Deficits in Sponsored Project Accounts
• Sponsored Award Reconciliation and Closeout
• Expense Monitoring
• Clearing Pre-encumbrances and Encumbrances

Office of Clinical Research Policies and Standard Operating Procedures

• 1.1 FDA Inspection
• 2.1 Obtaining Informed Consent
• 2.2 Pre-Screening for Human Subject Research
• 2.3 Determining Eligibility for Human Subject Research Studies
• 2.4 Preparation for a Subject Visit
• 2.5 Communication with Subjects
• 2.6 Epic and OnCore Subject Management Processes
  
• 2.7 Safety Reporting
• 2.8 Research Specimens
• UTMB Industry Funded Fee Policy

• ARC Policies and Procedures